Fitness criteria for Australian patients referred for chimeric antigen receptor T-cell therapy

Intern Med J. 2022 Aug;52(8):1454-1456. doi: 10.1111/imj.15868.
No abstract available

Publication types

  • Letter

MeSH terms

  • Australia / epidemiology
  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy, Adoptive
  • Receptors, Chimeric Antigen* / therapeutic use
  • T-Lymphocytes

Substances

  • Receptors, Chimeric Antigen